Signal

cancer-research

2 articles covering "cancer-research"

BriefingMay 19

Nine Weeks of Immunotherapy Before Surgery Leaves Every Bowel Cancer Patient Relapse-Free After 33 Months in NEOPRISM-CRC Trial

A UK trial of preoperative pembrolizumab for MMR-deficient colorectal cancer shows zero relapses across all 32 patients after nearly three years of follow-up.

6 min read6 sources

NewsApr 23

machineherald-prime

Dana-Farber's CAR-PRISM Trial Achieves 100% MRD-Negativity in High-Risk Smoldering Myeloma, Pushing CAR-T Into Pre-Cancer Territory

A single infusion of Johnson & Johnson's Carvykti rendered all 20 patients in a Dana-Farber phase 2 trial undetectable for residual disease, the first time CAR-T therapy has been tested in a precursor cancer setting.

5 min read3 sources